129 related articles for article (PubMed ID: 30944948)
21. It's official: SNM members endorse name change.
J Nucl Med; 2012 Jul; 53(7):13N. PubMed ID: 22753423
[No Abstract] [Full Text] [Related]
22. Cardiac ¹²³I-meta-iodobenzylguanidine scintigraphy in patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii peninsula, Japan.
Kokubo Y; Nomura Y; Morimoto S; Kuzuhara S
Parkinsonism Relat Disord; 2012 Mar; 18(3):306-8. PubMed ID: 21885322
[No Abstract] [Full Text] [Related]
23. The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases.
Ebert RF; Danthi NS; Charette MF; Hanspal M; Mondoro TH; Noel PJ; Olive M; Punturieri A; Moore TM
Circ Res; 2016 Jun; 118(12):1867-71. PubMed ID: 27283530
[TBL] [Abstract][Full Text] [Related]
24. SNMMI Leadership Update: FDA Approval of Imaging Agents: An Exciting Investment in Nuclear Medicine.
Schwarz SW
J Nucl Med; 2017 Jan; 58(1):20N. PubMed ID: 28062714
[No Abstract] [Full Text] [Related]
25. From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?
Potter BK
Clin Orthop Relat Res; 2016 Apr; 474(4):892-4. PubMed ID: 26872915
[No Abstract] [Full Text] [Related]
26. The Martinique Principles.
Ahuja S; Avram AM; Dillehay G; Greenspan BS; Gulec S; Van Nostrand D
J Nucl Med; 2019 Sep; 60(9):1334-1335. PubMed ID: 31227575
[No Abstract] [Full Text] [Related]
27. Introduction and Overview.
Czernin J; Mankoff D
J Nucl Med; 2016 Feb; 57 Suppl 1():1S-2S. PubMed ID: 26834097
[No Abstract] [Full Text] [Related]
28. Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum.
Waldman SA; Terzic A
Clin Pharmacol Ther; 2017 Jan; 101(1):8-12. PubMed ID: 27869291
[TBL] [Abstract][Full Text] [Related]
29. Online Social Media Practices in Nuclear Medicine and Molecular Imaging: A Concept to Incentivize Creation of Digital and Web-Based Content.
Wright CL; Niederkohr RD; Knopp MU; Knopp MV
J Nucl Med; 2017 Jun; 58(6):12N-14N. PubMed ID: 28572291
[No Abstract] [Full Text] [Related]
30. 2012 ISMRM Lauterbur Lecture. MRI: from science to society.
Lee VS
J Magn Reson Imaging; 2013 Apr; 37(4):753-60. PubMed ID: 23441004
[TBL] [Abstract][Full Text] [Related]
31. Managed care and nuclear medicine in the USA.
Sy WM
Ann Nucl Med; 1997 Feb; 11(1):1-6. PubMed ID: 9095315
[No Abstract] [Full Text] [Related]
32. A Conversation Between Joanna Fowler and Johannes Czernin.
Fowler JS; Czernin J
J Nucl Med; 2019 Sep; 60(9):1191-1193. PubMed ID: 31481591
[No Abstract] [Full Text] [Related]
33. From Bench to Bedside: Robotics and Navigation in Orthopaedics-Rise of the Machines or Just Rising Costs?
Potter BK
Clin Orthop Relat Res; 2019 Apr; 477(4):692-694. PubMed ID: 30844827
[No Abstract] [Full Text] [Related]
34. Medical physics in pre-clinical research.
Helbich T
Z Med Phys; 2014 Dec; 24(4):271. PubMed ID: 25193359
[No Abstract] [Full Text] [Related]
35. SNMMI industry forum created to work together on areas of promise.
J Nucl Med; 2015 Mar; 56(3):13N. PubMed ID: 25733601
[No Abstract] [Full Text] [Related]
36. Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
Czernin J
J Nucl Med; 2019 Aug; 60(8):1037. PubMed ID: 31371618
[No Abstract] [Full Text] [Related]
37. Nuclear Medicine, Molecular Imaging, and Theranostics: The Future Is Bright.
Czernin J; Calais J
J Nucl Med Technol; 2020 Jun; 48(Suppl 1):82S-83S. PubMed ID: 32605963
[No Abstract] [Full Text] [Related]
38. Brain wave hits California.
Shen H
Nature; 2014 Jun; 510(7506):456. PubMed ID: 24965632
[No Abstract] [Full Text] [Related]
39. Will the nuclear medicine industry survive?
Vermeeren PC
J Nucl Med; 1995 Jan; 36(1):17N-18N. PubMed ID: 7799072
[No Abstract] [Full Text] [Related]
40. A 'rule of 3' to revive Greek science, research and innovation.
Kollias G; Lambris JD
Nat Immunol; 2015 Dec; 16(12):1206-8. PubMed ID: 26580499
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
